News

What is the dosage of Hydrochlorothiazide and Triamterene? Adult- PO- The recommended dose is 1-2 tablets or capsules daily (25mg/37.5mg). The maximum dose is 75/50 mg daily.
Triamterene 37.5mg, hydrochlorothiazide 25mg; caps. Triamterene exerts its diuretic effect on the distal renal tubule to inhibit the reabsorption of sodium in exchange for potassium and hydrogen ...
Find out how to take Hydrochlorothiazide and Triamterene ... Adult- PO- The recommended dose is 1-2 tablets or capsules daily (25mg/37.5mg). The maximum dose is 75/50 mg daily.
Learn about side effects, uses, and more of hydrochlorothiazide oral tablet. It's a generic prescription drug that's used for high blood pressure and edema.
In the studies permitting comparison of triamterene with hydrochlorothiazide, the latter was consistently more effective as far as diuretic effect per se is concerned, a conclusion that also has ...
Triamterene 37.5mg, hydrochlorothiazide 25mg; scored tabs. Initially one Maxzide-25mg tab/day. Usual dosage: 1–2 Maxzide-25mg tabs or one Maxzide tab once daily. As a substitute for triamterene ...
For the record: 12:00 a.m. Dec. 30, 2002 For The Record Los Angeles Times Tuesday December 24, 2002 Home Edition Main News Part A Page 2 National Desk 19 inches; 707 words Type of Material: Correction ...
Lupin Pharmaceuticals is voluntarily recalling certain dosages of irbesartan tablets and irbesartan and hydrochlorothiazide tablets distributed in 30- and 90-count bottles nationwide.
Sales of Triamterene Hydrochlorothiazide 37.5/25mg Capsules, at Average Wholesale Price (AWP) were approximately $111 million for the 12 months ending October 2011, according to Wolters Kluwer.
Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and ...
Bolar Pharmaceutical Co.’s former director of regulatory affairs has pleaded guilty to federal criminal charges for lying to the U.S. Food and Drug Administration and falsifying company recor… ...